Cargando…

Half of UK patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation study

BACKGROUND: Patients with rheumatoid arthritis (RA) have shared care between rheumatologists and general practitioners (GPs). Rheumatologists guide immunosuppressive therapy, whilst GPs rely on analgesia and glucocorticoid (GC) therapy to manage active disease. The objective of this study was to des...

Descripción completa

Detalles Bibliográficos
Autores principales:	Black, Rachel J., Joseph, Rebecca M., Brown, Benjamin, Movahedi, Mohammad, Lunt, Mark, Dixon, William G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718024/ https://www.ncbi.nlm.nih.gov/pubmed/26702817 http://dx.doi.org/10.1186/s13075-015-0895-8

Ejemplares similares

Oral glucocorticoid therapy and all-cause and cause-specific mortality in patients with rheumatoid arthritis: a retrospective cohort study
por: Movahedi, Mohammad, et al.
Publicado: (2016)

The effect of glucocorticoid therapy on mortality in patients with rheumatoid arthritis and concomitant type II diabetes: a retrospective cohort study
por: Costello, Ruth E., et al.
Publicado: (2020)

Correction to: The effect of glucocorticoid therapy on mortality in patients with rheumatoid arthritis and concomitant type II diabetes: a retrospective cohort study
por: Costello, Ruth E., et al.
Publicado: (2021)

Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis
por: Movahedi, Mohammad, et al.
Publicado: (2016)

Perspectives of Glucocorticoid Use in Patients with Rheumatoid Arthritis
por: Venter, Gabriella, et al.
Publicado: (2021)

Low salivary cortisol levels in patients with rheumatoid arthritis exposed to oral glucocorticoids: a cross-sectional study set within UK electronic health records
por: Joseph, Rebecca M, et al.
Publicado: (2018)

The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Black, Rachel J., et al.
Publicado: (2016)

Glucocorticoids and chronotherapy in rheumatoid arthritis
por: Cutolo, Maurizio
Publicado: (2016)

Smoking‐Related Mortality in Patients With Early Rheumatoid Arthritis: A Retrospective Cohort Study Using the Clinical Practice Research Datalink
por: Joseph, Rebecca M., et al.
Publicado: (2016)

Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study
por: Jani, Meghna, et al.
Publicado: (2020)

Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription data
por: Joseph, Rebecca M., et al.
Publicado: (2018)

Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population
por: Mercer, Louise K., et al.
Publicado: (2013)

Quality of life, sleep and rheumatoid arthritis (QUASAR): a protocol for a prospective UK mHealth study to investigate the relationship between sleep and quality of life in adults with rheumatoid arthritis
por: Druce, Katie L, et al.
Publicado: (2018)

The perplexity of prescribing and switching of biologic drugs in rheumatoid arthritis: a UK regional audit of practice
por: Blake, Tim, et al.
Publicado: (2014)

Risks of smoking and benefits of smoking cessation on hospitalisations for cardiovascular events and respiratory infection in patients with rheumatoid arthritis: a retrospective cohort study using the Clinical Practice Research Datalink
por: Joseph, Rebecca M, et al.
Publicado: (2017)

Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry
por: Black, Rachel J., et al.
Publicado: (2017)

Polymorphisms in the glucocorticoid receptor gene that modulate glucocorticoid sensitivity are associated with rheumatoid arthritis
por: van Oosten, Manon JM, et al.
Publicado: (2010)

In vitro glucocorticoid sensitivity is associated with clinical glucocorticoid therapy outcome in rheumatoid arthritis
por: Quax, Rogier AM, et al.
Publicado: (2012)

Glucocorticoid receptor gene polymorphisms and susceptibility to rheumatoid arthritis
por: Donn, Rachelle, et al.
Publicado: (2007)

Why and how to optimize glucocorticoid treatment in rheumatoid arthritis
por: Cutolo, Maurizio
Publicado: (2012)

The use of glucocorticoids in rheumatoid arthritis - no 'rational' approach yet
por: Desai, Sonali P, et al.
Publicado: (2010)

Glucocorticoids in rheumatoid arthritis: current status and future studies
por: Hua, Charlotte, et al.
Publicado: (2020)

Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis
por: Riley, Thomas R, et al.
Publicado: (2021)

Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case–control analysis
por: Dixon, William G, et al.
Publicado: (2012)

The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses
por: Dixon, William G, et al.
Publicado: (2011)

Local administration of glucocorticoids decreases synovial citrullination in rheumatoid arthritis
por: Makrygiannakis, Dimitrios, et al.
Publicado: (2012)

Glucocorticoids and endothelial function in inflammatory diseases: focus on rheumatoid arthritis
por: Verhoeven, Frank, et al.
Publicado: (2016)

Glucocorticoid management in rheumatoid arthritis: morning or night low dose?
por: Paolino, Sabrina, et al.
Publicado: (2017)

292 Fibromyalgianess and Glucocorticoid Persistence Among Patients with Rheumatoid Arthritis
por: Wallace, Beth, et al.
Publicado: (2022)

The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids
por: Saag, Kenneth G., et al.
Publicado: (2022)

Viewpoint: Glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider
por: Boers, Maarten
Publicado: (2023)

Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
por: Spinelli, Francesca Romana, et al.
Publicado: (2023)

Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort
por: Movahedi, Mohammad, et al.
Publicado: (2022)

Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate
por: Humphreys, Jenny H, et al.
Publicado: (2017)

Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2018)

Utilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohort
por: Montes, Daniel, et al.
Publicado: (2023)

Biologics Prescribing for Rheumatoid Arthritis in Older Patients: A Single-Center Retrospective Cross-Sectional Study
por: Morsley, Klara, et al.
Publicado: (2015)

Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis
por: Kavanaugh, Arthur, et al.
Publicado: (2014)

Cortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy
por: Aeberli, Daniel, et al.
Publicado: (2013)

The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis
por: Cutolo, Maurizio, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lnascvdfhucpqu8570ck4slah1